These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 1541824

  • 1. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
    Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, Granelli-Piperno A, Bogdan C.
    J Immunol; 1992 Mar 15; 148(6):1858-63. PubMed ID: 1541824
    [Abstract] [Full Text] [Related]

  • 2. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW.
    J Immunol; 1988 Jun 01; 140(11):3971-7. PubMed ID: 3131421
    [Abstract] [Full Text] [Related]

  • 3. Role and effect of IL-2 in experimental visceral leishmaniasis.
    Murray HW, Miralles GD, Stoeckle MY, McDermott DF.
    J Immunol; 1993 Jul 15; 151(2):929-38. PubMed ID: 8335921
    [Abstract] [Full Text] [Related]

  • 4. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
    Squires KE, Schreiber RD, McElrath MJ, Rubin BY, Anderson SL, Murray HW.
    J Immunol; 1989 Dec 15; 143(12):4244-9. PubMed ID: 2512353
    [Abstract] [Full Text] [Related]

  • 5. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
    Murray HW, Stern JJ, Welte K, Rubin BY, Carriero SM, Nathan CF.
    J Immunol; 1987 Apr 01; 138(7):2290-7. PubMed ID: 3104456
    [Abstract] [Full Text] [Related]

  • 6. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.
    Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.
    J Infect Dis; 2003 Aug 01; 188(3):458-64. PubMed ID: 12870129
    [Abstract] [Full Text] [Related]

  • 7. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 8. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.
    Cenci E, Romani L, Vecchiarelli A, Puccetti P, Bistoni F.
    J Immunol; 1990 Jun 01; 144(11):4333-9. PubMed ID: 1971296
    [Abstract] [Full Text] [Related]

  • 9. Role and effect of TNF-alpha in experimental visceral leishmaniasis.
    Tumang MC, Keogh C, Moldawer LL, Helfgott DC, Teitelbaum R, Hariprashad J, Murray HW.
    J Immunol; 1994 Jul 15; 153(2):768-75. PubMed ID: 8021511
    [Abstract] [Full Text] [Related]

  • 10. Role of innate immune cells in protection against Toxoplasma gondii at inflamed site.
    Nakano Y, Hisaeda H, Sakai T, Zhang M, Maekawa Y, Zhang T, Himeno K.
    J Med Invest; 2001 Feb 15; 48(1-2):73-80. PubMed ID: 11286020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, Majumdar S.
    Scand J Immunol; 2007 Dec 15; 66(6):671-83. PubMed ID: 18021365
    [Abstract] [Full Text] [Related]

  • 15. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER, Varma TK, Fram RY, Lin CY, Koutrouvelis AP, Toliver-Kinsky TE.
    Clin Sci (Lond); 2001 Dec 15; 101(6):541-50. PubMed ID: 11724637
    [Abstract] [Full Text] [Related]

  • 16. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M, Yu WG, Umehara K, Iwasaki M, Wijesuriya R, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1998 Jun 01; 58(11):2426-32. PubMed ID: 9622084
    [Abstract] [Full Text] [Related]

  • 17. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
    Guilloteau L, Buzoni-Gatel D, Bernard F, Lantier I, Lantier F.
    Microb Pathog; 1993 Jan 01; 14(1):45-55. PubMed ID: 8321117
    [Abstract] [Full Text] [Related]

  • 18. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR, Rodig S, Telford SR, Satoskar AA, Ghosh SK, von Lichtenberg F, David JR.
    Eur J Immunol; 2000 Mar 01; 30(3):834-9. PubMed ID: 10741399
    [Abstract] [Full Text] [Related]

  • 19. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 01; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 20. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, Landolfo S, Forni G.
    J Immunol; 1988 Oct 15; 141(8):2831-6. PubMed ID: 3139768
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.